Clemens Warnke

5.5k total citations
117 papers, 2.2k citations indexed

About

Clemens Warnke is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Clemens Warnke has authored 117 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pathology and Forensic Medicine, 45 papers in Oncology and 30 papers in Neurology. Recurrent topics in Clemens Warnke's work include Multiple Sclerosis Research Studies (55 papers), Polyomavirus and related diseases (39 papers) and Full-Duplex Wireless Communications (19 papers). Clemens Warnke is often cited by papers focused on Multiple Sclerosis Research Studies (55 papers), Polyomavirus and related diseases (39 papers) and Full-Duplex Wireless Communications (19 papers). Clemens Warnke collaborates with scholars based in Germany, United States and Sweden. Clemens Warnke's co-authors include Bernd C. Kieseier, Hans‐Peter Hartung, Finja Schweitzer, Gereon R. Fink, Sarah Laurent, Olaf Stüve, Oezguer A. Onur, Nina N. Kleineberg, Xiangliang Chen and Mike P. Wattjes and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Clemens Warnke

109 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clemens Warnke Germany 28 819 659 593 294 276 117 2.2k
Bob W. van Oosten Netherlands 24 1.6k 1.9× 683 1.0× 630 1.1× 833 2.8× 515 1.9× 55 3.0k
Chava Perry Israel 24 502 0.6× 180 0.3× 520 0.9× 267 0.9× 391 1.4× 87 1.8k
Magnus Andersson Sweden 32 1.3k 1.6× 508 0.8× 386 0.7× 641 2.2× 583 2.1× 65 3.0k
Robert Hoepner Switzerland 19 543 0.7× 324 0.5× 292 0.5× 169 0.6× 178 0.6× 96 1.1k
Luigi Grimaldi Italy 25 654 0.8× 359 0.5× 219 0.4× 432 1.5× 507 1.8× 51 2.3k
Giovanni Grasso Italy 34 582 0.7× 997 1.5× 385 0.6× 198 0.7× 599 2.2× 203 4.2k
Celia Oreja‐Guevara Spain 28 1.8k 2.2× 726 1.1× 340 0.6× 430 1.5× 295 1.1× 137 2.6k
Zhi Chen China 33 285 0.3× 1.1k 1.7× 199 0.3× 263 0.9× 907 3.3× 228 3.8k
Hidenori Matsuo Japan 25 169 0.2× 669 1.0× 86 0.1× 357 1.2× 364 1.3× 110 1.8k
David Bennett Italy 29 140 0.2× 189 0.3× 177 0.3× 160 0.5× 731 2.6× 120 3.2k

Countries citing papers authored by Clemens Warnke

Since Specialization
Citations

This map shows the geographic impact of Clemens Warnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clemens Warnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clemens Warnke more than expected).

Fields of papers citing papers by Clemens Warnke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clemens Warnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clemens Warnke. The network helps show where Clemens Warnke may publish in the future.

Co-authorship network of co-authors of Clemens Warnke

This figure shows the co-authorship network connecting the top 25 collaborators of Clemens Warnke. A scholar is included among the top collaborators of Clemens Warnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clemens Warnke. Clemens Warnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellenberger, David, Niklas Frahm, Alexander Stahmann, et al.. (2025). Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis. Journal of Neurology. 272(9). 609–609.
2.
Goereci, Yasemin, Finja Schweitzer, Carsten Finke, et al.. (2024). Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage. Scientific Reports. 14(1). 5326–5326. 5 indexed citations
3.
Schild, Ann‐Katrin, Kim Klein, Yasemin Goereci, et al.. (2024). Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome. European Archives of Psychiatry and Clinical Neuroscience. 274(8). 1945–1957. 5 indexed citations
4.
Frahm, Niklas, David Ellenberger, Alexander Stahmann, et al.. (2024). Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry. Therapeutic Advances in Neurological Disorders. 17. 4233520828–4233520828. 3 indexed citations
5.
Warnke, Clemens, Christoph Adler, Stefan Bittner, et al.. (2024). Analysis of Cerebral CT Based on Supervised Machine Learning as a Predictor of Outcome After Out-of-Hospital Cardiac Arrest. Neurology. 103(1). e209583–e209583. 1 indexed citations
6.
Stahmann, Alexander, David Ellenberger, Niklas Frahm, et al.. (2024). Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations. Therapeutic Advances in Neurological Disorders. 17. 4233514132–4233514132. 3 indexed citations
7.
8.
Schild, Ann‐Katrin, Kim Klein, Yasemin Goereci, et al.. (2023). Subjective and Objective Cognitive Deficits in Patients with Post-COVID Syndrome. Zeitschrift für Neuropsychologie. 34(2). 99–110. 13 indexed citations
9.
Schweitzer, Finja, Sarah Laurent, Irene Cortese, et al.. (2023). Progressive Multifocal Leukoencephalopathy. Neurology. 101(16). 700–713. 20 indexed citations
10.
Grote‐Levi, Lea, Nora Möhn, Agnes Bonifacius, et al.. (2023). Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy. Neurology Neuroimmunology & Neuroinflammation. 10(5). 1 indexed citations
11.
Dillen, Kim, Yasemin Goereci, Veronika Dunkl, et al.. (2023). Cultural adaptation of the Integrated Palliative care Outcome Scale for neurological symptoms. Palliative & Supportive Care. 21(6). 1059–1068.
12.
Möhn, Nora, Lea Grote‐Levi, Franziska Hopfner, et al.. (2022). Innovative therapeutic concepts of progressive multifocal leukoencephalopathy. Journal of Neurology. 269(5). 2403–2413. 8 indexed citations
13.
Frahm, Niklas, David Ellenberger, Peter Flachenecker, et al.. (2022). Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry. Neurology and Therapy. 11(1). 319–336. 3 indexed citations
14.
Scheiderbauer, Jutta, Clemens Warnke, Sascha Köpke, et al.. (2022). Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies. Multiple Sclerosis and Related Disorders. 60. 103728–103728. 3 indexed citations
15.
Ellenberger, David, Peter Flachenecker, Tim Friede, et al.. (2021). Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry. Scientific Reports. 11(1). 13340–13340. 30 indexed citations
16.
Blaschke, Stefan, David Ellenberger, Peter Flachenecker, et al.. (2021). Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry. Multiple Sclerosis Journal. 28(6). 865–871. 9 indexed citations
17.
Kleineberg, Nina N., Samuel Knauß, Eileen Gülke, et al.. (2021). Neurological implications of COVID-19-results of the LEOSS registry. European Journal of Neurology. 28. 101–102. 1 indexed citations
18.
Goereci, Yasemin, et al.. (2021). Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination. SHILAP Revista de lepidopterología. 3(1). 52–52. 5 indexed citations
19.
Dehmel, Thomas, Norman Putzki, Bernd C. Kieseier, et al.. (2017). Cellular composition of peripheral blood mononuclear cells during 4 years long-term treatment with fingolimod (P5.364). Neurology. 88(16_supplement). 2 indexed citations
20.
Warnke, Clemens, et al.. (2009). Review of teriflunomide and its potential in the treatment of multiple sclerosis. SHILAP Revista de lepidopterología. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bob W. van Oosten Breakdown of academic impact, for papers by Chava Perry Breakdown of academic impact, for papers by Magnus Andersson Breakdown of academic impact, for papers by Robert Hoepner Breakdown of academic impact, for papers by Luigi Grimaldi Breakdown of academic impact, for papers by Giovanni Grasso Breakdown of academic impact, for papers by Celia Oreja‐Guevara Breakdown of academic impact, for papers by Zhi Chen Breakdown of academic impact, for papers by Hidenori Matsuo Breakdown of academic impact, for papers by David Bennett
Rankless by CCL
2026